From: Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics
No | Age (months) | Sex | YPT | YPM | CS | Treatment group | Risk group |
---|---|---|---|---|---|---|---|
1 | 19 | Male | O6 (1:640) | Negative | (−) | Conventional | Low |
2 | 29 | Female | O6 (1:160) | Negative | (−) | Conventional | Low |
3 | 72 | Male | O3 (1:640) | Negative | (−) | Conventional | Low |
4 | 6 | Male | Negative | Positive | (−) | Conventional | Low |
5 | 66 | Male | O5b (1:160) | Negative | (+) | Conventional | High |
6 | 34 | Female | O6 (1:160) | Negative | (−) | RAISE | Low |
7 | 22 | Male | O2b,5b (1:160) | Negative | (+) | RAISE | High |
8 | 70 | Male | O1a (1:160) | Negative | (−) | RAISE | Low |
9 | 21 | Female | O5a,5b (1:160) | Positive | (−) | RAISE | Low |
10 | 79 | Female | O6 (1:160) | Negative | (−) | RAISE | High |
11 | 21 | Female | O1b,2b (1:160) | Positive | (−) | RAISE | Low |